Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As more bacteria evolve to evade even last-resort drugs, ...

When the CDC released the 2019 Antibiotic Resistance Threats in the United States report, VRE was listed as a serious threat. Enterococci are bacteria that are normally present in the human intestines ...

One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum therapeutic drug products Second project proposal will focus on the Develop of new therapeutic drug candidates ...

Vancomycin-resistant enterococci are a common cause of healthcare-associated infection. A literature review was conducted to understand the current evidence and support nurses and other health ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

Please provide your email address to receive an email when new articles are posted on . The array of health care-associated infections, ranging from catheter-associated UTIs to Clostridioides ...

Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated with ...

Creating new vaccines is one of several possible strategies in the fight against antibiotic-resistant bacteria, in addition to using fewer antibiotics and using them smarter. One of the bacteria that ...